13 August 2018

Amedeo Smart

Independent Medical Education

Subscriber: th..@boehringer-ingelheim.com

HIV Infection

13 August 2018 | n=35

  1. Zhang X, Ding X, Zhu Y, Chong H, et al.
    Structural and functional characterization of HIV-1 cell fusion inhibitor T20.
    AIDS 2018.

  2. Nunez O, Hernando V, Diaz A.
    Estimating the number of people living with HIV and the undiagnosed fraction in Spain in 2013.
    AIDS 2018.

  3. Lledo GM, Carrasco I, Benitez-Gutierrez LM, Arias A, et al.
    Regression of liver fibrosis after curing chronic hepatitis C with oral antivirals in patients with and without HIV coinfection.
    AIDS 2018.

  4. Kamitani E, Wichser ME, Adegbite AH, Mullins MM, et al.
    Increasing prevalence of self-reported HIV pre-exposure prophylaxis (PrEP) use in published surveys - a systematic review and meta-analysis.
    AIDS 2018.

  5. Price JC, Seaberg EC, Stosor V, Witt MD, et al.
    AST-to-platelet ratio index increases significantly 3 years prior to liver-related death in HIV-hepatitis-coinfected men.
    AIDS 2018.

  6. Colin De Verdiere N, Durier C, Samri A, Meiffredy V, et al.
    Immunogenicity and safety of yellow fever vaccine in HIV-1-infected patients: ANRS EP46 NOVAA.
    AIDS 2018.

  7. Delaugerre C, Rodriguez C, Capitant C, Nere ML, et al.
    Drug resistance among patients who acquired HIV infection in a PrEP trial.
    AIDS 2018.

  8. Shiboski CH, Yao TJ, Russell JS, Ryder MI, et al.
    The association between oral disease and type of antiretroviral therapy among perinatally HIV-Infected youth.
    AIDS 2018.

  9. Kroon E, Pham PT, Sirivichayakul S, Trichavaroj R, et al.
    Transmission dynamics among participants initiating anti-retroviral therapy upon diagnosis of early acute HIV-1 infection in Thailand.
    AIDS 2018.

  10. Rhines AS, Feldman MW, Bendavid E.
    Modeling the implementation of population-level isoniazid preventive therapy for tuberculosis control in a high HIV-prevalence setting.
    AIDS 2018.

  11. Cynamon MH, Damianopoulos EN.
    Modeling the HIV-1 Antiretroviral Therapeutic Drug Interaction.
    AIDS Res Hum Retroviruses 2018.

  12. Ezeonwumelu I, Bartolo I, Martin F, Abecasis AB, et al.
    Accidental father-to-son HIV-1 transmission during the seroconversion period.
    AIDS Res Hum Retroviruses 2018.

  13. Li K, Ou W, Feng Y, Sun J, et al.
    Near Full-Length Genomic Characterization of a Novel HIV Type 1 Recombinant Form (CRF01_AE/B) Identified from Anhui, China.
    AIDS Res Hum Retroviruses 2018.

  14. Dhamanage A, Thakar M, Paranjape RS.
    HIV-1 mediated suppression of IFN-alpha production is associated with inhibition of IRF-7 translocation and PI3K/akt pathway in Plasmacytoid Dendritic cells.
    AIDS Res Hum Retroviruses 2018.

  15. Haddow LJ, Godi C, Sokolska M, Cardoso MJ, et al.
    Brain perfusion, regional volumes and cognitive function in HIV positive patients treated with protease inhibitor monotherapy.
    Clin Infect Dis 2018.

  16. Spinelli MA, Scott HM, Vittinghoff E, Liu AY, et al.
    A Panel Management and Patient Navigation Intervention is Associated with Earlier PrEP Initiation in A Safety-Net Primary Care Health System.
    J Acquir Immune Defic Syndr 2018.

  17. Christensen-Quick A, Chaillon A, Yek C, Zanini F, et al.
    Influenza Vaccination Can Broadly Activate the HIV Reservoir During Antiretroviral Therapy.
    J Acquir Immune Defic Syndr 2018.

  18. Rosenberg NE, Bhushan NL, Vansia D, Phanga T, et al.
    Comparing Youth Friendly Health Services to the Standard of Care through "Girl Power-Malawi": A Quasi-Experimental Cohort Study.
    J Acquir Immune Defic Syndr 2018.

  19. Bukowski LA, Chandler CJ, Creasy SL, Matthews DD, et al.
    Characterizing the HIV Care Continuum and Identifying Barriers and Facilitators to HIV Diagnosis and Viral Suppression among Black Transgender Women in the United States.
    J Acquir Immune Defic Syndr 2018.

  20. Namazi G, Fajnzylber JM, Aga E, Bosch R, et al.
    The Control of HIV after Antiretroviral Medication Pause (CHAMP) study: post-treatment controllers identified from 14 clinical studies.
    J Infect Dis 2018.

  21. Darcis G, Berkhout B.
    HIV resistance to dolutegravir: are we looking at the wrong place?
    J Infect Dis 2018.

  22. Kahyesh-Esfandiary R, Sadigh ZA, Esghaei M, Bastani MN, et al.
    Detection of HCV Genome in Peripheral Blood Mononuclear Cells of Iranian Seropositive and HCV RNA negative in Plasma of Patients with Beta-thalassemia Major: Occult HCV Infection.
    J Med Virol 2018.

  23. Flores GL, Cruz HM, Miguel JC, Potsch DV, et al.
    Assessing Hepatitis B immunity using dried blood spot samples from HIV(+) individuals.
    J Med Virol 2018.

  24. Rankovic S, Ramalho R, Aiken C, Rousso I, et al.
    PF74 reinforces the HIV-1 capsid to impair reverse transcription-induced uncoating.
    J Virol 2018.

  25. Chong H, Zhu Y, Yu D, He Y, et al.
    Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against HIV-1, HIV-2, and Simian Immunodeficiency Virus.
    J Virol 2018.

  26. Phillips B, Van Rompay KKA, Rodriguez-Nieves J, Lorin C, et al.
    Adjuvant-dependent enhancement of HIV Env-specific antibody responses in infant rhesus macaques.
    J Virol 2018.

  27. Carnes SK, Zhou J, Aiken C.
    HIV-1 Engages a Dynein-Dynactin-BICD2 Complex for Infection and Transport to the Nucleus.
    J Virol 2018.

  28. Osei Kuffour E, Schott K, Jaguva Vasudevan AA, Holler J, et al.
    USP18 (UBP43) Abrogates p21-Mediated Inhibition of HIV-1.
    J Virol 2018.

  29. Wang Z, Wang W, Cui YC, Pan Q, et al.
    HIV-1 employs multiple mechanisms to resist Cas9/sgRNA targeting the viral primer binding site.
    J Virol 2018.

  30. Anang S, Kaushik N, Hingane S, Kumari A, et al.
    Potent inhibition of hepatitis E virus release by a cyclic peptide inhibitor of the interaction between viral open reading frame 3 protein and host tumor susceptibility gene 101.
    J Virol 2018.

  31. Pan T, Peng Z, Tan L, Zou F, et al.
    Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Potently Inhibit the Replication of Zika Viruses by Inducing the Degradation of AXL.
    J Virol 2018.

  32. Okoye AA, Hansen SG, Vaidya M, Fukazawa Y, et al.
    Early antiretroviral therapy limits SIV reservoir establishment to delay or prevent post-treatment viral rebound.
    Nat Med 2018.

  33. Blignaut E, Rossouw TM, Becker PJ, Mavuso DS, et al.
    Gingival Recession and Localized Aggressive Periodontitis Among HIV-Infected Children and Adolescents Receiving Antiretroviral Therapy.
    Pediatr Infect Dis J 2018.

  34. Meier K, Jaguva Vasudevan AA, Zhang Z, Bahr A, et al.
    Equine MX2 is a restriction factor of equine infectious anemia virus (EIAV).
    Virology 2018;523:52-63.

  35. Nunes JM, Furtado MN, de Morais Nunes ER, Sucupira MCA, et al.
    Modulation of epigenetic factors during the early stages of HIV-1 infection in CD4(+) T cells in vitro.
    Virology 2018;523:41-51.

Display articles in

Amedeo HIV Infection

Data Origin

You selected the following journals for your Amedeo HIV Infection newsletter:

AIDS, AIDS Res Hum Retroviruses, Ann Intern Med, BMJ, Clin Infect Dis, J Acquir Immune Defic Syndr, J Clin Immunol, J Clin Invest, J Infect Dis, J Med Virol, J Virol, JAMA, Lancet, N Engl J Med, Nat Med, Pediatr Infect Dis J, Science, Virology.

To modify the journal selection, please open your Newsletter Management Page. If you don't remember the URL, please submit the email address of your Amedeo subscription.

Your email:

Amedeo HIV Infection

Five-Week Literature

13 August 2018

06 August 2018

30 July 2018

23 July 2018

16 July 2018

13 August 2018

Multidisciplinary Journal Club

  1. Menzies D, Adjobimey M, Ruslami R, Trajman A, et al.
    Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults.
    N Engl J Med. 2018;379:440-453.

  2. Huang DT, Yealy DM, Filbin MR, Brown AM, et al.
    Procalcitonin-Guided Use of Antibiotics for Lower Respiratory Tract Infection.
    N Engl J Med. 2018;379:236-249.

  3. Ghosn J, Taiwo B, Seedat S, Autran B, et al.
    Lancet. 2018 Jul 23. pii: S0140-6736(18)31311.

Every week, Amedeo's Multidisciplinary Journal Club (MJC) presents a selection of outstanding articles. Take a look beyond the horizon.

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016